International Clinical Trial: Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137039) titled 'Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen' on Aug. 15.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: The First Affiliated Hospital of Xiamen University

Condition: Locally Advanced Hypopharyngeal Cancer

Intervention: Drug: Adebrelimab+Albumin paclitaxel +Cisplatin

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: August 20, 2025

Target Sample Size: 34

Countries of Recruitmen...